Heather Cheng is an Oncology physician affiliated with University of Washington. OpenAlex indexes 325 publications with 16,494 citations (h-index 44); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-288-1000Registry record last updated 18 Mar 2014.
Clinical trials
- Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Sponsor: SWOG Cancer Research Network
- PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Sponsor: Prostate Cancer Clinical Trials Consortium
- Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Sponsor: University of Washington
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20233 payments
- Janssen Research & Development, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
70.6%Cytochrome P450 17A1 Inhibitor24.6%Abiraterone Acetate100%Part D≥15 patientsAndrogen Receptor Inhibitor20.6%Xtandi53%Bicalutamide47%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
23.8%Corticosteroid23.8%Prednisone100%Part D≥20 patientsGenitourinary & hormones
5.6%alpha-Adrenergic Blocker5.6%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2025 per NIH RePORTER. The latest:
- Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality
Fred Hutchinson Cancer Center
FY2025$237,841P50CA097186 - Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality
Fred Hutchinson Cancer Center
FY2024$475,269P50CA097186 - Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality
Fred Hutchinson Cancer Center
FY2023$523,852P50CA097186
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network
2025 - Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”